| Objective:To analyze the prognostic factors of non-Hodgkin’s lymphoma(NHL) and to investigate the prognosis value of peripheral blood absolute lymphocyte count(ALC) peripheral blood absolute monocyte count(AMC)ã€the ratio of the absolute lymphocyte count to the absolute monocyte count (ALC/AMC ratio).Methods:We retrospective analyzed data from229patients diagnosisd as non-Hodgkin’s lymphoma by pathology from January2007to September2012, to study the correlation between clinical parametersã€pathological featuresã€treatments [such as sexã€age〠Ann Arbor stageã€the number of extranodal sites of diseaseã€Eastern Cooperative Oncology Group performance statusã€B symptomsã€pathological patternã€origin of cellã€lactate dehydrogenase(LDH)ã€the international prognostic index(IPI)ã€the revised International Prognostic Index (R-IPI)ã€bone marrow involvementã€bone destructionã€mediastinum involvementã€hepatosplenomegalyã€serous cavity effusionã€bulkyã€the peripheral blood absolute hemoglobin count(HB)ã€the peripheral blood absolute lymphocyte countã€the peripheral blood absolute monocyte countã€ALC/AMC ratioã€autotransplantationã€allotransplantation] and5years overall survival (OS)ã€5year event-free survival(EFS).Results:The median patient age was46(4.8-83) years, the median follow-up time was300(6-2610) days. In univariate analysis age>60years, origin of cell was B cell lymphoma, pathological pattern was follicular lymphoma, without B symptom, the number of extranodal sites of disease<2, Eastern Cooperative Oncology Group performance status<2, normal LDH, Ann Arbor stage â… -â…¡, low IPI score or low R-IPI score, without bone marrow involvement, without hepatosplenomegaly, without serous cavity effusion, without mediastinum involvement, HB>=110g/l, ALC=1000/ul, AMC... |